![Michael R. Simon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Michael R.
Simon is the founder of Secretory IgA, Inc. He is currently a Professor at Wayne State University (Michigan).
He holds a doctorate degree from New York University.
Aktive Positionen von Michael R. Simon
Unternehmen | Position | Beginn |
---|---|---|
Secretory IgA, Inc.
![]() Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Gründer | 20.09.2011 |
Wayne State University (Michigan) | Corporate Officer/Principal | 20.09.2011 |
Ausbildung von Michael R. Simon
New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Secretory IgA, Inc.
![]() Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI. | Health Technology |